Verona raises $80M, lists on NASDAQ

Respiratory disease company Verona Pharma plc (LSE:VRP; NASDAQ:VRNA) traded flat on NASDAQ Thursday, ending the day at

Read the full 179 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE